Skip to main content

Finding a Clinical Trial

If you're interested in the possibility of a clinical trial as a treatment option, talk with your doctor first. He or she can help you find an eligible trial.

You can also contact one of The Leukemia & Lymphoma Society's (LLS's) Information Specialists for help in finding an appropriate clinical trial. We can help you identify the information you need about your diagnosis and treatment history to determine eligible trials. We can also help you develop a list of questions to ask your doctor or the trial team about participating in a trial.


Contacting the Trial Team

If your doctor agrees that a clinical trial is a good option, he or she can contact the trial team, which will ask many questions related to your medical and treatment history to determine if the trial is right for you.

At times, you may need to contact the trial team yourself about participating if your doctor is unable to. If this is the case, an LLS information specialist can help guide you and suggest what to ask the trial team.

When you contact a member of the trial team, ask to speak with the study coordinator, the referral coordinator or the protocol assistant.

The study coordinator answers your and your doctor's questions. He or she will make preliminary assessment of your eligibility for the trial. After your initial appointment with the coordinator, he or she decides whether you'll be accepted to participate in the clinical trial.

 

Informed Consent

When you first express interest in a clinical trial, a process called informed consent begins. Informed consent is the term used to describe the ongoing sharing of information by the trial team before, during and after the clinical trial.

To start the process, the clinical trial team gives you an informed consent document with detailed written information about the trial, and the doctors and nurses involved in the trial can explain the study to help you decide if you want to participate. You'll be encouraged to ask questions so you have all the information you need to make a decision about participating. (A language interpreter is provided for people who request one.)

You will be given time to review the clinical trial details in the informed consent document.

 

Next Steps

Once you and the trial team are satisfied that you understand the clinical trial protocol (procedures), you must agree to sign an informed consent document before you can begin. It affirms that you fully understand the nature of the study. The informed consent document is not a contract; you're free to leave the study if any new information leads you to want to do so. In fact, you're free to leave the study at any time, for any reason.

New information may become available to the research team as the trial goes along. The clinical trial protocol may also change over time. The informed consent process requires that members of the research team update you as such changes are made. You may also be asked to sign a new informed consent document.

Blood Cancer United resources

Find free, specialized guidance and information for every type of blood cancer, request financial support, find emotional support, and connect with other members of the blood cancer community.

We are Blood Cancer United.

Everyone affected by blood cancer—patients, survivors, caregivers, researchers, advocates, fundraisers, everyone—has a story. Share yours.
A group of friends stands together on a red carpet at a Light The Night event, holding glowing lanterns and signs supporting the Leukemia & Lymphoma Society. The warm lights and close embraces create a powerful sense of unity, love, and hope—reflecting the strength and solidarity shared by those honoring and supporting people whose lives have been touched by blood cancer.

Olivia

acute lymphoblastic leukemia (ALL)

Photo of Jan, Lymphoma survivor

Jan

Lymphoma

woman wearing green tee shirt outside

Sally

Large B-cell lymphoma (DLBCL)

Three individuals stand together on a stage at a Leukemia & Lymphoma Society Student Visionaries of the Year event, with one holding an award plaque and another holding a bouquet of flowers—highlighting recognition, advocacy, and community impact in the blood cancer awareness and fundraising community.

Andrew

diffuse large B-cell lymphoma (DLBCL)

Here’s an SEO‑friendly, descriptive alt text option that includes **blood cancer** while accurately reflecting the image you uploaded:  **Alt text:**   A person stands in a bright indoor hallway wearing a light checkered shirt, posing for a professional portrait used in materials that raise awareness about blood cancer.

Tony

leukemia

A person standing beside a brown horse with a white facial stripe holds a lead rope in an outdoor paddock under a bright blue sky. The horse wears a blue halter, and the scene conveys calm companionship while supporting blood cancer awareness through human–animal connection.

Siri

acute myeloid leukemia (AML)

Here is descriptive, SEO‑driven alt text that includes **blood cancer**, stays objective, and avoids assumptions:  **Alt text:**   Person walking in a hospital hallway while pushing an IV pole with multiple infusion pumps, wearing a face mask and casual clothing, with tubing connected to a chest port during blood cancer treatment; patient care rooms and medical equipment are visible along the corridor.

Jeff

diffuse large B-cell lymphoma (DLBCL)

Copilot said: Person stands outdoors holding an illuminated lantern at a Light The Night event, with a large screen in the background showing participants raising lights and the message “Thank you for bringing light to the darkness of cancer,” highlighting advocacy, community support, and awareness in the blood cancer community.

Natalia

splenic marginal zone non-Hodgkin lymphoma (MZL)

zeke-j_dam_file_161236.jpg

Zeke

acute lymphoblastic leukemia (B-ALL)

Lila wearing warm clothes-standing in front of a 'top of Mt. Kilimanjaro' sign with arms raised

Lila

acute myeloid leukemia (AML)

Snapshot of Ashley wearing black jacket with Find the Cure printed, a cancer survivor

Ashley

chronic myelogenous leukemia (CML)

Snapshot of Zachariah holding flowers, a cancer survivor

Zach

Hodgkin lymphoma (HL)

The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.